William L. Heyward
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von William L. Heyward
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA.
11
| Extinct | Biotechnology | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von William L. Heyward
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member | |
| IR BIOSCIENCES HOLDINGS, INC. | Biotechnology | Director/Board Member | |
| TITAN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| HUMANIGEN, INC. | Biotechnology | General Counsel | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | General Counsel | |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Internet Software/Services | Corporate Officer/Principal Sales & Marketing | |
| ATRECA, INC. | Biotechnology | Director/Board Member | |
| ALZHEON, INC. | Biotechnology | Director/Board Member | |
| ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
| University of Oxford | College/University | Graduate Degree Doctorate Degree | |
| Golden Gate University | College/University | Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| Wyeth-Ayerst Research | Chief Tech/Sci/R&D Officer | ||
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member | |
| Yamaguchi University | College/University | Doctorate Degree | |
Hyde Engineering + Consulting, Inc.
 Hyde Engineering + Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Hyde Engineering + Consulting, Inc. provides engineering services. The firm’s services include commissioning and qualification, cleaning programs, hyde’s core lab, case studies, custom services, automation and project management. The company was founded in 1993 and is headquartered in Boulder, CO. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Episcopal Relief & Development Corp.
 Episcopal Relief & Development Corp. Miscellaneous Commercial ServicesCommercial Services Episcopal Relief & Development Corp. operates as a relief and development agency. It works with Church partners and other local organizations to save lives and transforms communities worldwide. The company was founded in 1940 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin | |
| Temple University Beasley School of Law | College/University | Graduate Degree | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | General Counsel | |
| KEZAR LIFE SCIENCES, INC. | Biotechnology | Director/Board Member | |
| FMB Research | Miscellaneous | Chief Executive Officer | |
Caprion Proteomics, Inc.
 Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Caprion Proteomics, Inc. provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. It specializes in proteomics, biomarkers, discovery, validation, services, immune monitoring, flow cytometry and elispot areas. The company was founded by Neil Cashman and Martin LeBlanc in 2000 and is headquartered in Montreal, Canada. | Medical Specialties | Director/Board Member | |
| APPLIED THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| RAIN ONCOLOGY INC. | Biotechnology | Director/Board Member | |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor | |
| Golden Gate Bioventures LLC | Corporate Officer/Principal | ||
Walking Fish Therapeutics, Inc.
 Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Walking Fish Therapeutics, Inc. engages in the provision of immune therapy services. It offers treatment for oncology, rare deficiency disease, regenerative medicine, and infectious disease. The company was founded by Lewis T. Williams, Mark Selby, Seenu Kothakota, and Tom Brennan and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
| SATELLOS BIOSCIENCE INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 43 |
| Kanada | 7 |
| Vereinigtes Königreich | 2 |
| Japan | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Finance | 3 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 60 |
| Corporate Officer/Principal | 25 |
| Independent Dir/Board Member | 18 |
| Chief Tech/Sci/R&D Officer | 11 |
| Undergraduate Degree | 10 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- William L. Heyward
- Unternehmensverbindungen
